Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis

  1. Katrina E. Donahue, MD, MPH;
  2. Gerald Gartlehner, MD, MPH;
  3. Daniel E. Jonas, MD, MPH;
  4. Linda J. Lux, MPA;
  5. Patricia Thieda, MA;
  6. Beth L. Jonas, MD;
  7. Richard A. Hansen, PhD;
  8. Laura C. Morgan, MA; and
  9. Kathleen N. Lohr, PhD
  1. From the University of North Carolina and Cecil G. Sheps Center for Health Services Research, Chapel Hill, North Carolina; RTI International, Research Triangle Park, North Carolina; Danube University, Krems, Austria; and Ludwig Boltzmann Institute for Health Technology Assessments, Vienna, Austria.
    1. Figure.
      View larger version:
      Figure. Study flow diagram.

      Numbers of included articles and included studies differ because some studies have multiple publications. RCT = randomized, controlled trial.

    Responses to this article

    « Previous | Next Article »Table of Contents